VFV. I. Fedorchenko

V. I. Fedorchenko

*This is an algorithmically generated author record based on publicly available information.

V. I. Fedorchenko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ANTIBIOTIC SENSITIVITY SPECTRUM OF CLINICAL ISOLATES OF SPHINGOMONAS PAUCIMOBILIS

    by V. I. Fedorchenko, M. M. Ananieva, H. A. Loban, N. I. Hasiuk, O. I. Melashchenko

    Introduction. Sphingomonas paucimobilis is a Gram-negative, non-fermenting bacterium widely distributed in the natural environment and known for its resistance to disinfectants commonly used in healthcare settings. Human infections have been reported sporadically in both immunocompromised and immunocompetent individuals. However, data regarding the antimicrobial susceptibility patterns of this microorganism remain limited and fragmented in the literature. Objective: To determine the antibiotic susceptibility profile of clinical strains of S. paucimobilis isolated from the pharynx of children with recurrent tonsillitis and to identify antimicrobial agents suitable for empirical therapy. Materials and methods. A bacteriological approach was employed. Quantitative cultures were performed using the sector plating method on Columbia agar (bioMérieux, France). Final identification of pure isolates was carried out using the automated VITEK® 2 Compact system (bioMérieux, France). Antimicrobial susceptibility testing was performed using the standardized disk diffusion method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines on Mueller–Hinton agar. Due to the slow growth characteristics of S. paucimobilis, inhibition zones were measured after 72 hours of incubation. Results. Three isolates of S. paucimobilis were recovered from nasopharyngeal specimens of five children, in clinically significant concentrations. Overall, the isolates demonstrated susceptibility to most tested antibiotics. The greatest variability in susceptibility was observed for the combination drug co-trimoxazole, with inhibition zone diameters differing by 1.7-fold between isolates 1 and 3. The lowest susceptibility was recorded for aztreonam, with inhibition zone diameters measuring less than 11 mm. Conclusions. For empirical treatment of infections caused by S. paucimobilis, β-lactam antibiotics combined with clavulanic acid, piperacillin–tazobactam, and carbapenems appear to be the most appropriate options. Rifampicin may be considered in cases of resistance to other antimicrobial agents.

  • Open Access

    DYSBIOTIC CHANGES IN THE PHARYNGAL MICROBIOTA: THE EPIDEMIOLOGIC ROLE OF SPHINGOMONAS PAUCIMOBILIS

    by V. I. Fedorchenko, M. M. Ananieva, G. A. Loban, N. I. Gasyuk, I. A. Zaytsev

    Introduction. Sphingomonas paucimobilis is a Gram-negative bacterium widely distributed in natural environments and healthcare settings and is known for its relative resistance to disinfectants. Human infections of various localizations have been reported sporadically. The slow growth of this microorganism on culture media, compared to most pathogenic bacteria and representatives of the normal human microbiota, may contribute to the limited data regarding its prevalence in the human microbiome and surrounding environments. Objective: To quantify the presence of S. paucimobilis in the pharyngeal microbiota of children with recurrent tonsillitis and to assess the potential epidemiological role of colonized individuals as sources of environmental contamination. Materials and methods: A bacteriological approach was employed. Quantitative cultures were performed using the sector plating method on Columbia agar supplemented with 5% sheep blood (bioMérieux, France). Final identification of isolated pure cultures was carried out using the automated VITEK® 2 Compact system (bioMérieux, France). Results. Three isolates of S. paucimobilis were recovered from nasopharyngeal specimens of five children. In two cases, S. paucimobilis was detected in association with Staphylococcus aureus, while in one case it was isolated in monoculture. The detection of S. paucimobilis in clinically significant concentrations in children with recurrent tonsillitis suggests that colonization of the pharyngeal mucosa may not be incidental. This may be related to age-associated features of the immune system and the recurrent inflammatory condition of the examined cohort. The relatively high prevalence and concentration of S. paucimobilis in the studied group indicate the potential for colonized patients to serve as reservoirs and possible sources of environmental dissemination. Conclusions. The presence of S. paucimobilis in significant concentrations among children with recurrent tonsillitis suggests a potential epidemiological role of colonized individuals as sources of environmental contamination and transmission.